DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today a poster presentation of the ...

The event brings together design, art and performance student scholars as well as faculty mentors and jurors, in an effort to foster further academic collaboration in the college ... the public is an ...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...

Tribune News NetworkDoha Weill Cornell Medicine-Qatar (WCM-Q) recently hosted its second annual Student Research Forum, showcasing 66 impressive scientific posters that demonstrate student innovation ...

Binghamton University concluded its weeklong Research Days celebration with student poster sessions covering a variety of ...

About 100 undergrads and 40 graduate students gathered to present their research findings, exchange ideas and network with ...

30th World Congress on Parkinson's Disease and Related Disorders, being held May 7th-10th in New York City, NY. Details of the oral and poster presentation are as follows: ...

today announced that the company will present three posters related to both of its pipeline programs at the American Thoracic Society (ATS) 2025 International Conference (ATS 2025). ATS 2025 is ...

Presentation materials will be made available on the company's website following the event. Acceptance of an abstract for poster presentation at a prestigious conference highlights TScan ...

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference in Chicago, highlighting the safety and efficacy of its product, ADG126, an anti-CTLA-4 masking antibody, in combination ...

This “trial-in-progress” presentation will focus on the design of the ongoing expansion portion of Mersana’s Phase 1 clinical trial of Emi-Le that is actively enrolling patients with triple ...